Pritelivir: Phase II started

AiCuris began the double-blind, crossover, U.S. Phase II AIC316-01-II-02 trial to compare 100 mg oral AIC316 once daily vs. 500 mg oral valacyclovir once daily for 28 days in about 90 HSV-2-infected p...